Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 4Classical hematology 4Myeloid 2Lymphoid 2Gynecologic 2Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2Radiation Injuries 1Drug-Related Side Effects and Adverse Reactions 1Anemia 1

Interventions

Paclitaxel 575Carboplatin 521Cisplatin 351Bevacizumab 252pembrolizumab 228Gemcitabine 157Topotecan 128Cyclophosphamide 128liposomal doxorubicin 127olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 81niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 57Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Erythropoietin × Gynecologic × Clear all
NCT00017004 2017-08-09

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

GOG Foundation

Phase 3 Completed
114 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

NCT00348738 2007-11-02

Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome

Medical University of Vienna

Phase 3 Unknown
300 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡